Related Experiment Video
Updated: Jan 31, 2026
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Cardiac Lymphatics Predict Survival After Heart Transplantation
Sydney C Ginn1,2, Anamaria Dragan2, Benoit A Niclou2
1Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University Atlanta GA USA.
Insights
Reduced cardiac lymphatics after heart transplant are linked to increased cardiac allograft vasculopathy (CAV) and higher patient mortality. Lymphatic area may predict transplant outcomes and risk for CAV.
Area of Science:
- Cardiology
- Transplant Immunology
- Vascular Biology
Background:
- Cardiac allograft vasculopathy (CAV) is a primary cause of late graft loss and reduced survival post-orthotopic heart transplantation (OHT).
- Severed cardiac lymphatics during OHT may disrupt homeostasis, potentially influencing CAV development and outcomes.
- This study investigates the relationship between cardiac lymphatic variations and CAV in OHT patients.
Purpose of the Study:
- To examine if variations in cardiac lymphatics influence CAV development and outcomes after OHT.
- To determine if lymphatic area in endomyocardial biopsies can serve as a predictive marker for CAV and mortality.
- To explore the potential therapeutic role of lymphangiogenic pathways in improving OHT outcomes.
Main Methods:
- A single-center, retrospective case-control study involving 50 OHT patients.
- Endomyocardial biopsies were collected at 1 and 5 years post-OHT.
- CAV severity was graded using angiograms, and lymphatic density (lymphatics/mm²) was quantified.
Main Results:
- A significant inverse correlation was observed between lymphatic area and CAV severity.
- Patients with lower lymphatic areas one year post-OHT exhibited higher mortality rates (40% vs. 12%).
Conclusions:
- Reduced cardiac lymphatics are associated with increased CAV and mortality risk in OHT recipients.
- Lymphatic area quantification may identify patients at higher risk for adverse outcomes.
- Further research is needed to validate these findings, explore clinical confounders, and investigate therapeutic strategies targeting lymphangiogenesis.
Background:
Cardiac allograft vasculopathy (CAV) is the leading cause of late allograft loss and a major factor limiting long-term survival after orthotopic heart transplantation (OHT). Cardiac lymphatics are severed at the time of donor heart explantation and not surgically reconstructed, potentially disrupting homeostatic processes. We examined whether variations in cardiac lymphatics could influence CAV and OHT outcomes by using endomyocardial biopsies.
Methods:
The study is a single-center, blinded, retrospective case-control study using endomyocardial biopsies from 50 patients with primary OHT in the Emory Transplant Center (Atlanta, GA). Routine endomyocardial biopsies were obtained at 1 and 5 years after OHT, and angiograms were graded for CAV (no CAV0, n=26; CAV1, n=12; CAV2-3, n=12).
Results:
When the number of lymphatics/mm2 was quantified in these patients, lymphatic area was found to be inversely correlated to CAV severity. Moreover, patients with lower lymphatic areas 1 year after OHT had higher mortality compared with their high lymphatic counterparts (nlow=25; nhigh=25; 40% versus 12%, P=0.0196).
Conclusions:
These findings indicate a potential association between reduced lymphatics and CAV, where upon further validation lymphatic area might serve as a measurable parameter to identify patients at risk for CAV and mortality. Because the survival analysis included limited adjustments, additional studies will be needed to incorporate key clinical confounders capable of influencing the relationship between lymphatic development and OHT outcomes. Future studies should investigate the mechanistic link between cardiac lymphatics and CAV and if lymphangiogenic pathways have therapeutic potential to improve OHT outcomes.
Related Concept Videos
01:18Physiology of the Heart: The Cardiac Cycle
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
01:19Cardiac Output I:Effect of Heart Rate on Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
01:21Cardiac Catheterization II: Right Heart Catheterization
01:15Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
01:27Anatomy of the Heart
01:24Cardiac Catheterization III: Left Heart Catheterization